Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202. Case and Commentary Jan 2005 Confidential Care for Minors and Protecting Genetic Information, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):53-60. doi: 10.1001/virtualmentor.2005.7.1.ccas10c-0501.
Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.
In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202.
Case and Commentary Jan 2005 Confidential Care for Minors and Protecting Genetic Information, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):53-60. doi: 10.1001/virtualmentor.2005.7.1.ccas10c-0501.